HighLife announced today that it received CE mark approval for its transcatheter mitral valve replacement (TMVR) system.

HighLife plans to prioritise procedural consistency and imaging-guided follow-up for safety in early commercial settings.

HighLife Receives CE Mark Approval for its TMVR SolutionParis, January 26, 2026 – HighLife SAS, a leading MedTech company focused on ...

VANCOUVER, BC, Aug. 28, 2024 /PRNewswire/ - In a world, where cardiovascular diseases (CVDs) remain a leading cause of death, the global cardiac surgery market has emerged as a cornerstone of ...

DENVER, CO — Two cardiac valve prostheses, similar in capability, offer the prospect of significant relief of mitral regurgitation (MR) via transcatheter mitral-valve replacement (TMVR) for patients ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A transapical transcatheter mitral valve repair system ...

NEW YORK CITY -- Mitral valve technology developers were urged to go back to the drawing board due to current-generation devices not meeting the needs of enough patients with mitral regurgitation (MR) ...

Edwards Lifesciences announced Thursday that the California company has completed three first-in-human implants of the company’s transcatheter mitral valve replacement system. But it is not the only ...

Abbott Laboratories has received approval for a mitral valve replacement that can be implanted without open-heart surgery. The U.S. Food & Drug Administration gave the OK for the North Chicago-based ...